They cytoplasmic protein NARG1 (NMDA (N-methyl-d-aspartate) receptor-regulated gene 1) interacts with ARD1 or ARD2 to form a complex, which exhibits N-terminal (alpha) acetyltransferase activity. This complex interacts with ribosomal subunits functioning in cotranslational acetylation. During apoptosis, both NARG1 and ARD1 are cleaved by caspases, which results in decreased acetyltransferase activity. Knockdown of NARG1 in HeLa cells leads to apoptosis, indicating that properly functioning NARG1 is essential for cell viability. NARG1 is expressed at high levels in dividing tissues such as bone marrow, testis and embryonal brain and it is overexpressed in papillary thyroid carcinomas. The NARG1-like protein (NARG1L) is an 864 amino acid protein that contains 7 TPR repeats and may also be a component of a complex that displays N-terminal acetyltransferase activity.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIFELISA
recommended for detection of NARG1L of mouse, rat and human origin by WB, IF and ELISA non cross-reactive with all other isoforms also reactive with additional species, including equine, canine, bovine, porcine and avian
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope mapping within an internal region of NARG1L of human origin
Tissue Specificity
epitope mapping within an internal region of NARG1L of human origin
recommended for detection of NARG1L of mouse, rat and human origin by WB, IF and ELISA non cross-reactive with all other isoforms also reactive with additional species, including equine, canine, bovine, porcine and avian
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.